Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

The Hollywood Strikes Are Over. Here's When You Could See Your Favorite Stars and Shows Return

Missed your favorite actors? After nearly four months of striking, they're coming back.

Stocks Mixed As Market Continues to Look to Extend Positive Streak

Stocks were mixed as the market continues to look to extend its positive streak.

Apple Co-Founder Steve Wozniak Reportedly Hospitalized in Mexico

Apple co-founder Steve Wozniak was reportedly hospitalized Wednesday after fainting at an event at the World Business Forum in Mexico City.

Disney Reports Better-Than-Expected Quarterly Profit

Disney Reports Better-Than-Expected Quarterly Profit

Hollywood Actors Reach Deal With Studios After Nearly Four-Month Strike

The contract agreement reached Wednesday must still be approved by the union's board and its members, but the leadership said actors will be allowed to return to work starting Thursday.

Stretching Your Dollar: What to Know About the Crypto Surge

What to Know About the Crypto Surge

Stretching Your Dollar: Thanksgiving Dinner on A Budget

Preparing Thanksgiving Dinner on a budget.

Adidas Says Demand for Samba Shoes Exceeds Supply

Adidas Says Demand for Samba Shoes Exceeds Supply

Warner Bros. Discovery Says Strikes Will Impact 2024 Results

Warner Bros. Discovery Says Strikes Will Impact 2024 Results

Amazon to Offer Primary Care to Prime Members

Amazon to Offer Primary Care to Prime Members

Load More